INTRATECT 10% sol perf 10 g/100ml i.v. vial 100 ml

7680629130031 CH-62913 J06BA02 08.09.

Reimbursement limitations:

INTRATECT2

Admis uniquement en cas de déficits immunitaires, de purpuras idiopathiques thrombocytopéniques, de syndrome de Guillain-Barré, …

INTRATECT 10% sol perf 10 g/100ml i.v. vial 100 ml
INTRATECT 10% sol perf 10 g/100ml i.v. vial 100 ml
INTRATECT 10% sol perf 10 g/100ml i.v. vial 100 ml
1 / 3
google

Details

Product number
6291301
CPT
-
Packaging group
100
Unit
ml
Composition
proteina plasmatis humani 100 mg ex illo immunoglobulinum humanum normale min. 96 %, glycinum, natrii hydroxidum corresp. natrium max. 0.046 mg, acidum hydrochloridum, aqua ad iniectabile, ad solutionem pro 1 ml.

Articles (1)

Intratect 10%, Infusionslösung
Infusionslösung
100
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance WIZUS
(N/A)
- Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 736.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2013

Authorization holder

Biotest (Schweiz) AG

5102 Rupperswil

Authorization information

Swissmedic authorization number
62913
Drug name
Intratect 10%, Infusionslösung
Galenic form
LSINF
ATC Code
J06BA02
Authorization status
Z
Dispensation category
B
First authorization
13/09/2013
Authorization expiration date
31/12/9999
IT number
08.09.
Domain
Human medicine
Field of application
Immunmodulation bei idiopathischer thrombozytopenischer Purpura (ITP) Immunmodulation bei Kawasaki-Syndrom allogene Knochenmarktransplantation Substitutionstherapie bei primären Immunmangelkrankheiten Substitutionstherapie bei Myelom oder chronisch-lympathischer Leukämie mit schwerer sekundärer Hypogammaglobulinänämie und rezidivierenden Infektionen Immunmodulation bei Gullain-Barré Syndrom (GBS) Substitutionstherapie bei Kindern mit kongenitalem AIDS und rezidivierenden Infektionen

Packaging details

Description (FR)
INTRATECT 10% sol perf 10 g/100ml i.v. vial 100 ml
Description (DE)
INTRATECT 10% Inf Lös 10 g/100ml i.v. Vial 100 ml
Market launch
13/09/2013
Narcotic (BTM)
No

Other packaging sizes

INTRATECT 10% sol perf 1 g/10ml i.v. vial 10 ml
10 ML
GTIN: 7680629130017
View
INTRATECT 10% sol perf 5 g/50ml i.v. vial 50 ml
50 ML
GTIN: 7680629130024
View
INTRATECT 10% sol perf 20 g/200ml i.v. vial 200 ml
200 ML
GTIN: 7680629130048
View